...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO CEO Slides Up

The only thing I noticed is that BIO CEO slide 1 is dated February.  Glad we are getting such great updates.

masila

Share
New Message
Please login to post a reply